Related Experiment Video
Updated: Mar 15, 2026

04:56
An Efficient Single—Person Technique for Milk Sampling from Laboratory Mice
Published on: March 28, 2025
1.9K
Lactoferrin Levels in Human Milk after Preterm and Term Delivery
Marzia Albenzio1, Antonella Santillo1, Ilaria Stolfi2
1Department of the Sciences of Agriculture, Food and Environment, University of Foggia, Foggia, Italy.
American Journal of Perinatology
|September 8, 2016
Summary
Lactoferrin (LF) levels in human milk are higher for preterm infants and decrease over time. This variability highlights differing infant needs and informs tailored LF supplementation strategies.
Area of Science:
- Human milk composition
- Neonatal nutrition
- Glycoprotein analysis
Background:
- Lactoferrin (LF) is a key functional glycoprotein in human milk with anti-infective and immunomodulatory properties.
- Limited data exist on LF concentration changes in maternal milk over lactation, especially concerning infant gestational age (GA).
Purpose of the Study:
- To determine lactoferrin (LF) levels in human milk from mothers of preterm and term infants.
- To evaluate variations in LF concentration over time (colostrum to mature milk) and by infant GA.
Main Methods:
- Milk samples collected from 28 mothers at 0-72 hours, 5-7 days, and >10 days postpartum.
- Samples categorized by infant GA: 24-27.6 (I), 28-31.6 (II), 32-34.6 (III), 35-37.6 (IV), and >38 weeks (V).
- Lactoferrin (LF) content analyzed using SDS-PAGE.
Main Results:
- Infant GA and time of sampling significantly affected LF levels in human milk.
- Higher LF content was observed in milk from mothers of extremely preterm infants (GA 24-27.6 weeks) (p<0.01).
- LF levels showed a significant decreasing trend over time, with highest concentrations in milk for infants with birth weight <1400g.
Conclusions:
- Human milk lactoferrin (LF) levels exhibit significant variability influenced by lactation stage and infant gestational age.
- This dynamic LF concentration may correspond to the evolving nutritional and immunological needs of infants.
- Findings support the development of individualized LF supplementation protocols for neonates in clinical and home settings.
Related Concept Videos
Development of Immunocompetence
1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Transcytosis of IgG
4.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.4K

